Foghorn Therapeutics
Carlos brings over 20 years of experience in organizational and human capital management acquired from working in the biotech, pharma and consumer goods industries around the world.
Prior to joining the company, Carlos held various roles of increasing responsibility at Biogen, in multiple areas and geographies ranging from human resources business partner for Spain, Portugal, and Italy, to HR lead for Global Commercial functions in the United States and the Emerging Market region. In his most recent role at Biogen, Carlos was the Head of Human Resources for Europe, Canada, and International Partner Markets.
Before joining Biogen, Carlos spent 10 years serving as HR Business Partner in companies like Gillette and Roche, where he built teams, lead transformations and served as strategic partner to the business.
Carlos holds a BS in Law from UNED in Spain and received his Human Resources Master’s degree from EADA in Barcelona. He also holds a PDD from IE Instituto de Empresa, Madrid and the Executive Leadership Program at Harvard Business School, Boston.
Foghorn Therapeutics
1 followers
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Their proprietary Gene Traffic Control platform gives them an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing them to identify, validate, and potential drug targets within the system.